SAN FRANCISCO, CA—Among patients with complex coronary lesions, guiding PCI with either optical coherence tomography or intravascular ultrasound appears to yield similar results, according to a ...

MIAMI BEACH, FL—Three-year registry data show the BioMimics 3D stent performs well in femoropopliteal lesions that are long, have chronic total occlusion (CTO), or have moderate/severe calcification, ...

Patients with CKD had twice the risk of target vessel failure after PCI compared with patients without CKD. The benefits of intravascular imaging-guided percutaneous coronary intervention (PCI) extend ...

Please provide your email address to receive an email when new articles are posted on . A bioadaptor implant adaptable to vessel physiology conferred better outcomes from 6 months to 1 year vs. a DES.

Please provide your email address to receive an email when new articles are posted on . Intravascular imaging-guided PCI was tied to better vessel-related and clinical outcomes compared with ...

A new study published in the journal of Cardiovascular Revascularization Medicine revealed that in patients with complex left ...

Data regarding clinical outcomes after intravascular imaging–guided percutaneous coronary intervention (PCI) for complex coronary-artery lesions, as compared with outcomes after angiography-guided PCI ...

Late-breaking INFINITY-SWEDEHEART Randomized Clinical Trial (RCT) data evaluating DynamX ® Coronary Bioadaptor System’s unique mechanism of action among patients with Acute Coronary Syndrome (ACS) and ...

Improvements in bifurcation stent techniques, the results from randomized controlled trials and registry data have led to the conclusion that stenting of the main vessel and provisional side-branch ...

WASHINGTON--(BUSINESS WIRE)--Elixir Medical, a developer of disruptive technologies to treat cardiovascular disease, today announced late-breaking data demonstrating significant benefit of the DynamX ...